Company Information
USD
12.49
- (-%)
NASDAQ:CDMO, AVID BIOSERVICES, INC.
Industry: Biotechnology
End of Day: 6 February 2025 GMT-4
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Address
14191 Myford Road
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Gregory P. Sargen
Director
Dr. Joseph Carleone,PhD
Chairman of the Board/Director
Mr. Richard A. Richieri
COO
Dr. Catherine J. Mackey, PhD
Director
Ms. Jeanne Thoma
Director
Mr. Mark R. Ziebell
General Counsel/Secretary/Vice President
Mr. Richard B. Hancock
Director
Mr. Daniel Ryan Hart
CFO/Chief Accounting Officer
Mr. Nicholas S. Green
CEO/Director/President
Dr. Esther Alegria, PhD
Director
Mr. Matthew R. Kwietniak
Other Executive Officer
Ownership
Institution Holdings
BlackRock Inc
5,281,444 (8.352%)
State Street Corporation
4,784,239 (7.565%)
T. Rowe Price Investment Management,Inc.
4,352,252 (6.882%)
Millennium Management LLC
4,240,147 (6.705%)
SSGA Funds Management Inc
4,063,383 (6.425%)
Vanguard Group Inc
3,617,873 (5.721%)
T. Rowe Price
3,020,457 (4.776%)
AltraVue Capital, LLC
2,974,333 (4.703%)
Royal Bank of Canada
2,481,215 (3.924%)
BlackRock Fund Advisors
2,316,585 (3.663%)
Funds Holdings
SPDR® S&P Biotech ETF
3,579,325 (5.660%)
T. Rowe Price Small-Cap Stock Fund
2,031,231 (3.212%)
T. Rowe Price US Small-Cap Core Equity
2,031,231 (3.212%)
iShares Russell 2000 ETF
1,534,262 (2.426%)
Palisade Small Cap Core Equity
1,153,506 (1.824%)
T. Rowe Price U.S. Small-Cap Core Eq Tr
976,689 (1.544%)
Vanguard Institutional Extnd Mkt Idx Tr
938,316 (1.484%)
T. Rowe Price Instl Small-Cap Stock Fund
886,483 (1.402%)
iShares Russell 2000 Growth ETF
549,003 (0.868%)
Fidelity Extended Market Index Fund
350,430 (0.554%)
Make Smart Investment Choices